Noyori asymmetric hydrogenation catalysts

E580172

Noyori asymmetric hydrogenation catalysts are highly efficient chiral ruthenium complexes that enable enantioselective hydrogenation of ketones and related substrates, revolutionizing asymmetric synthesis in organic chemistry.

All labels observed (2)

How this entity was disambiguated

Statements (46)

Predicate Object
instanceOf asymmetric hydrogenation catalyst ⓘ
chiral ruthenium complex ⓘ
homogeneous transition metal catalyst ⓘ
advantage broad substrate scope ⓘ
low catalyst loading ⓘ
predictable stereochemical outcome ⓘ
application industrial asymmetric hydrogenation processes ⓘ
synthesis of chiral alcohols ⓘ
synthesis of pharmaceutical intermediates ⓘ
catalystGeneration second‑generation asymmetric hydrogenation catalysts ⓘ
coordinationEnvironment octahedral ruthenium complex ⓘ
developer Ryoji Noyori ⓘ
feature high enantioselectivity ⓘ
high turnover frequency ⓘ
high turnover number ⓘ
operates under mild conditions ⓘ
well‑defined chiral environment ⓘ
field asymmetric synthesis ⓘ
organic chemistry ⓘ
hydrogenSource isopropanol in transfer hydrogenation ⓘ
molecular hydrogen ⓘ
impact revolutionized asymmetric hydrogenation of ketones ⓘ
ligandType chiral diamine ligand ⓘ
chiral diphosphine ligand ⓘ
mechanism bifunctional metal–ligand catalysis ⓘ
mechanisticStep concerted hydride and proton transfer ⓘ
metalCenter ruthenium ⓘ
reactionType asymmetric hydrogenation of imines ⓘ
asymmetric hydrogenation of ketones ⓘ
asymmetric hydrogenation of β‑keto esters ⓘ
transfer hydrogenation of ketones ⓘ
recognition contributed to 2001 Nobel Prize in Chemistry for Ryoji Noyori ⓘ
relatedConcept Noyori–Ikariya catalyst system ⓘ
selectivityType enantioselective ⓘ
solventCompatibility polar aprotic solvents ⓘ
polar protic solvents ⓘ
stereocontrolElement axially chiral diphosphine ligand ⓘ
chiral diamine ligand ⓘ
substrateType prochiral imine ⓘ
prochiral ketone ⓘ
β‑keto ester ⓘ
typicalLigand BINAP ⓘ
DPEN ⓘ
SEGPHOS ⓘ
typicalOxidationState Ru(II) ⓘ
usedIn large‑scale production of chiral drugs ⓘ

How these facts were elicited

Referenced by (2)

Full triples — surface form annotated when it differs from this entity's canonical label.

Ryoji Noyori → notableWork → Noyori asymmetric hydrogenation catalysts ⓘ
Noyori asymmetric hydrogenation catalysts → relatedConcept → Noyori–Ikariya catalyst system ⓘ
linked to: Noyori asymmetric hydrogenation catalysts